Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

NCT04299048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia
Non-Small-Cell Lung Cancer
Pancreatic Cancer
Colorectal Cancer

Interventions

DRUG: PF-06946860

Sponsor

Pfizer